You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cladribine

Showing 126 - 150 of 172
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematopoietic System--Cancer Trial in Beijing (Cyclophosphamide)

Unknown status
  • Hematopoietic System--Cancer
  • Beijing, Chaoyang District, China
    Yan Yue
Aug 30, 2018

Systemic Mastocytosis Trial in Toledo (Cladribine and pegylated interpheron alpha-2a)

Unknown status
  • Systemic Mastocytosis
  • Cladribine and pegylated interpheron alpha-2a
  • Toledo, Spain
    Instituto de Estudios de Mastocitosis de Castilla La Mancha; Hos
Aug 26, 2016

Lymphoma Trial in Canada, United States (cladribine)

Completed
  • Lymphoma
  • cladribine
  • Scottsdale, Arizona
  • +20 more
Dec 5, 2016

Non-Hodgkin's Lymphoma Trial in Columbus (Clofarabine)

Completed
  • Non-Hodgkin's Lymphoma
  • Columbus, Ohio
    Ohio State University
Dec 4, 2017

Multiple Sclerosis Trial (Cladribine, Pantoprazole)

Completed
Has Results
  • Multiple Sclerosis
  • (no location specified)
Mar 15, 2016

Systemic Mastocytosis, Aggressive (ASM), Leukemia, Mast Cell, Hematological Non-mast Cell Lineage Disease (AHNMD) Trial in

Completed
Has Results
  • Systemic Mastocytosis, Aggressive (ASM)
  • +2 more
  • Stanford, California
  • +2 more
Sep 19, 2018

Acute Myeloid Leukemia Trial in Guangzhou (hematopoietic stem cell microtransplantation-long-term, hematopoietic stem cell

Unknown status
  • Acute Myeloid Leukemia
  • hematopoietic stem cell microtransplantation-long-term
  • +3 more
  • Guangzhou, Guangdong, China
    Nanfang Hospital, Southern Medical University
Dec 6, 2017

Lymphoma, Extranodal NK-T-Cell Trial in Chengdu (GLIDE)

Unknown status
  • Lymphoma, Extranodal NK-T-Cell
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Nov 6, 2017

Cancer, Chronic Myelomonocytic Leukemia Trial in Salt Lake City (Clofarabine)

Terminated
Has Results
  • Cancer
  • Chronic Myelomonocytic Leukemia
  • Salt Lake City, Utah
    Huntsman Cancer Institute
May 25, 2017

After Vemurafenib / BRAF Inhibitors Interruption in

Unknown status
  • Erdheim-Chester Disease
    • New York, New York
    • +1 more
    Oct 27, 2016

    Brain and CNS Tumors Trial run by the NCI (chemo, cladribine, radiation therapy)

    Completed
    • Brain and Central Nervous System Tumors
    • Bethesda, Maryland
      Radiation Oncology Branch
    Apr 28, 2015

    Cold Agglutinin Disease, Autoimmune Hemolytic Anemia Trial in Denmark, Finland, Norway (Bendamustine, Rituximab)

    Completed
    • Cold Agglutinin Disease
    • Autoimmune Hemolytic Anemia
    • Bendamustine, Rituximab
    • Copenhagen, Denmark
    • +7 more
    Jan 6, 2017

    Rituximab in Hairy Cell Leukemia:Multicenter Retrospective Study

    Completed
    • Hairy-cell Leukemia
    • Data collection
    • Reims, France
      Chu de Reims
    Aug 25, 2016

    Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia Trial in Vallhala (Clofarabine)

    Completed
    • Acute Lymphoblastic Leukemia
    • Acute Myelogenous Leukemia
    • Vallhala, New York
      New York Medical College
    Mar 23, 2016

    Leukemia Trial in Tampa (CLAG Regimen, Gleevec®)

    Completed
    Has Results
    • Leukemia
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jun 17, 2014

    Leukemia Trial in Detroit, Grosse Pointe Woods (bryostatin 1, cladribine)

    Completed
    • Leukemia
    • bryostatin 1
    • cladribine
    • Detroit, Michigan
    • +2 more
    Apr 22, 2014

    Multiple Sclerosis, Relapsing-Remitting Trial (Cladribine 5.25 mg/kg, Cladribine 3.5 mg/kg, Placebo)

    Completed
    Has Results
    • Multiple Sclerosis, Relapsing-Remitting
    • Cladribine 5.25 mg/kg
    • +2 more
    • (no location specified)
    Jan 10, 2014

    Hematologic Tumors, Lymphoproliferative Disorders, Leukemia Trial in Houston (Clofarabine)

    Completed
    • Hematologic Neoplasms
    • +3 more
    • Houston, Texas
      University of Texas M. D. Anderson Cancer Center
    Mar 24, 2015

    Hairy Cell Leukemia (HCL) Trial in Germany (2CdA +/- Rituximab)

    Completed
    • Hairy Cell Leukemia (HCL)
    • 2CdA +/- Rituximab
    • Ansbach, Germany
    • +46 more
    Jun 3, 2014

    Leukemia Trial in Worldwide (filgrastim, cladribine, idarubicin)

    Completed
    • Leukemia
    • filgrastim
    • +2 more
    • Birmingham, Alabama
    • +234 more
    Jul 24, 2014

    Leukemia Trial in Rochester (filgrastim, cladribine, cytarabine)

    Completed
    • Leukemia
    • filgrastim
    • +3 more
    • Rochester, New York
      James P. Wilmot Cancer Center at University of Rochester Medical
    Oct 14, 2013

    Leukemia, Myeloid, Acute Trial in St. Louis (Clofarabine)

    Completed
    • Leukemia, Myeloid, Acute
    • St. Louis, Missouri
      Washington University
    Nov 10, 2014

    Leukemia Trial in Australia, Canada, United States (biological, drug, procedure, radiation)

    Completed
    • Leukemia
    • filgrastim
    • +12 more
    • Long Beach, California
    • +37 more
    Jul 23, 2014

    Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria, Acute Myelogenous Leukemia Trial in La Jolla (Nonmyeloablative Allogeneic

    Unknown status
    • Aplastic Anemia
    • +17 more
    • Nonmyeloablative Allogeneic Transplant
    • La Jolla, California
      Scripps Green Hospital
    Dec 5, 2013

    Leukemia, Myeloid, Acute Trial in St. Louis (Granulocyte colony-stimulating factor (G-CSF), Cladribine, Cytarabine)

    Completed
    • Leukemia, Myeloid, Acute
    • Granulocyte colony-stimulating factor (G-CSF)
    • +4 more
    • St. Louis, Missouri
      Washington University School of Medicine
    Jul 22, 2013